Unilever to close Henderson ice cream manufacturing facility in Nevada
June 25, 2019
Gold soars to six-year high as trade, Iran tensions mount
June 25, 2019

AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan

Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.

Powered by WPeMatico